CytoMed Therapeutics Market Cap

CytoMed Therapeutics has a market cap or net worth of $23.71 million as of May 3, 2024. Its market cap has decreased by -35.73% in one year.

Market Cap

23.71M

Enterprise Value

16.75M

1-Year Change

-35.73%

Ranking

#4913

Market Cap Chart

Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $23.71M, a decrease of -48.58%. That is a compound annual growth rate of -46.86%.

Market Cap History

Date	Market Cap	% Change
May 2, 2024	24.20M	-2.02%
May 1, 2024	24.70M	1.65%
Apr 30, 2024	24.30M	-4.33%
Apr 29, 2024	25.40M	4.96%
Apr 26, 2024	24.20M	-4.72%
Apr 25, 2024	25.40M	2.42%
Apr 24, 2024	24.80M	-
Apr 23, 2024	24.80M	-4.62%
Apr 22, 2024	26.00M	7.88%
Apr 19, 2024	24.10M	-
Apr 18, 2024	24.10M	0.84%
Apr 17, 2024	23.90M	-2.05%
Apr 16, 2024	24.40M	4.72%
Apr 15, 2024	23.30M	-3.72%
Apr 12, 2024	24.20M	-0.41%
Apr 11, 2024	24.30M	2.10%
Apr 10, 2024	23.80M	1.28%
Apr 9, 2024	23.50M	-
Apr 8, 2024	23.50M	1.73%
Apr 5, 2024	23.10M	-2.12%
Apr 4, 2024	23.60M	-2.88%
Apr 3, 2024	24.30M	1.25%
Apr 2, 2024	24.00M	-6.98%
Apr 1, 2024	25.80M	3.20%
Mar 28, 2024	25.00M	-3.10%

View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lumos Pharma	24.65M
Qilian International Holding Group	24.63M
Nephros	24.57M
Bullfrog AI	24.42M
Lisata Therapeutics	24.34M
Exagen	23.87M
Sol-Gel Technologies	23.68M
Ekso Bionics Holdings	23.09M

Market Cap Rankings